SCFAs can boost cellular metabolism and memory potential in CD8+ T cells [99], which may mean that SCFAs can promote a favourable tumour microenvironment in bladder cancer, in which T-cell inflamed tumours [100] with increased FOXP3+ Treg infiltration [101] have been associated with improved patient survival. This evidence concerns the gene FOXP3 and neoplasm.